Multiple Sclerosis and other Neurological Conditions
ZORAH O. IRIEMI, MA
Philadelphia College of Osteopathic Medicine
Stone Mountain, Georgia, United States
Monica S. Branch, MD
Assistant Professor
Emory University School of Medicine
Atlanta, Georgia, United States
ZORAH O. IRIEMI, MA
Philadelphia College of Osteopathic Medicine
Stone Mountain, Georgia, United States
Background:
Cerebral fat embolism syndrome (CFES) is a rare but life-threatening complication of sickle cell disease (SCD), often precipitated by parvovirus B19–induced marrow necrosis. Functional recovery among survivors is poorly described, and systemic inequities in rehabilitation access disproportionately affect uninsured and minoritized patients.
Case:
A 33-year-old African-American woman with Hb S–β thalassemia, previously independent in activities of daily living (ADLs) and childcare, presented with parvovirus-induced aplastic crisis complicated by CFES. She developed profound neurological and functional deficits, including Rancho IV–VI cognition, maximal assistance for mobility, and dysphagia requiring nocturnal tube feeds. Despite being uninsured, she was admitted to a safety-net inpatient rehabilitation unit. Over 13 days of intensive interdisciplinary therapy, supported by methylphenidate for cognitive fatigue, she achieved independent bed mobility, supervised ambulation of 200 feet, and improved self-care and medication management.
Discussions:
Her recovery illustrates three lessons: (1) survival from CFES must be distinguished from functional recovery; (2) early physiatric involvement reframes prognosis and drives stepwise gains across mobility, cognition, and ADLs; and (3) systemic inequities in SCD care and rehabilitation access remain critical determinants of outcome. Safety-net structures enabled her recovery, whereas in many centers, lack of insurance would have precluded IRU admission.
Conclusions:
This case underscores the indispensable role of physiatry in restoring function after CFES and the urgent need to prioritize equitable rehabilitation access. For patients with SCD and other marginalized groups, ensuring access to rehabilitation is both a clinical necessity and a moral imperative.